Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus shell and protrusion virus-like particle platform.
Albireo Pharma, Inc. (NASDAQ: ALBO) dropped 23.5% to $19.00 after the company reported worse-than-expected Q2 EPS results and filed for a mixed shelf of up to $400 million.